By analyzing the relationship between FTH1, FTL, HMOX1, SLC11A2, SLC39A14 and TFRCDACH1 and the clinical pathological stages of HCC, we found that the expression of these genes increased gradually in Stage I, Stage II and Stage III. Here, SLC39A14 is linked to hepatocellular carcinoma.